University of Texas's MD Anderson Cancer Center: Ultrasound-Guided Microbubbles Boost Immunotherapy Efficacy
May 31, 2022
May 31, 2022
HOUSTON, Texas, May 31 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on May 30, 2022:
* * *
MD Anderson developed a platform to improve both antitumor immune responses and responses to checkpoint inhibitors
* * *
Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and . . .
* * *
MD Anderson developed a platform to improve both antitumor immune responses and responses to checkpoint inhibitors
* * *
Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and . . .